Large study on milk: Risky for women but not for men

The risk of ischemic heart disease (IHD) and acute myocardial infarction (MI) increased for women with milk intake levels higher than 2 glasses per day, while n...

Who pays for Rebecca Doe – and all of us?

Anna Törner on how easily we get used to the idea that healthcare is free - when it really is about how and who pays for it

u2-Lok – rostfria dubbelklämringskopplingar för trygg drift

I industriella miljöer där vätskor och gaser transporteras under högt tryck eller vakuum krävs pålitliga förbindelser. u2-Lok från Schwer Fittings, tillgänglig ...

Microscope and measuring machine in one

ZEISS O-INSPECT duo covers two essential applications in quality assurance.

Moderna develops mRNA vaccine against norovirus

A highly anticipated vaccine is in late clinical evaluation and could be ready for approval within a couple of years. The target is the norovirus, often called ...

Career coach on salaries: “There is no right or wrong”

What is a reasonable salary for my job? It's a question we all ask ourselves. But how important is a higher salary really? Career coach Tina Persson believes th...

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

KI-forskare har upptäckt biomarkörer för postcovid

Forskare vid Karolinska institutet har i en ny studie identifierat en uppsättning proteiner i blod hos personer med långvariga besvär av postcovid.

Spara upp till 62% av din luftförbrukning med nya Air Management System från SMC.

Automatisk sänkning av trycket i produktionspaus minskar läckage och onödig förbrukning.

Carl Borrebaeck – professor and serial entrepreneur with a taste for speed

Award-winning cancer researcher, the founder of many listed companies, and constantly in the academic and commercial spotlight for decades. However, Carl Borreb...

She is CSL Behring's new Nordic General Manager

Since the beginning of january, Helena Bragd is the new Nordic General Manager for the biotech company CSL Behring and CEO of CSL Behring AB.

Gothenburg, the city of life science – We are ‘Little Boston’

Western Sweden is investing in life science within everything from advanced therapeutic drugs to femtech. At the same time, stakeholders are looking to other in...

Han får vetenskapspris för upptäckten av den inflammatoriska reflexen

Den amerikanske neurokirurgen och uppfinnaren Kevin J. Tracey tilldelas Hans Wigzells Forskningsstiftelses vetenskapliga pris på 100 000 dollar. Han får det bla...

High biological age is linked to a higher risk of dementia and stroke

It is a well-known fact that people age at different rates, and a recent study at the Karolinska Institute suggests that people with a biological age higher tha...

RegFile AB

Optimize Courier SUPPLIERS (DISTRIBUTORS)

High-performance Slide Scanner for Fluorescence, Brightfield and Polarization

ZEISS Axioscan 7 combines high speed digitization and outstanding image quality.

Smarta flödesmätare från OEM Automatic

För verksamheter som vill säkra driften och samtidigt förenkla integrationen, erbjuder OEM Automatic nu LABOPLUS och OMNIPLUS från Senseca – två innovativa flöd...

Biobank Sverige får miljontillskott i satsning på kliniska prövningar

Biobank Sverige tilldelas tio miljoner kronor som en del av etableringen av Swetrial, ett nytt nationellt kansli med uppdrag att stärka Sveriges position inom k...

ZEISS at EMO Hannover 2025

Experience some of the most exciting highlights from our ZEISS product portfolio.

Non-destructive testing and assembly control

Assess complete assembly.

Lilly recruits top Swedish researcher in Alzheimer´s

One of Sweden's leading Alzheimer's researchers, Oskar Hansson, has been recruited by pharma giant Eli Lilly and will be moving to the USA.

First preterm infants study – a vital step for Neola

After years of developing an advanced lung monitoring system, Neola Medical has received some delightful news: permission to start its first clinical study on p...

Failed to read the fine print – lost his life’s work

A celebrated CEO and co-founder of a pioneering lab company one moment – the next, fired, kicked out and written out of the company’s history. This is the story...